Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BIMEKIZUMAB-BKZX Cause Incorrect dose administered? 209 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 209 reports of Incorrect dose administered have been filed in association with BIMEKIZUMAB-BKZX. This represents 3.9% of all adverse event reports for BIMEKIZUMAB-BKZX.

209
Reports of Incorrect dose administered with BIMEKIZUMAB-BKZX
3.9%
of all BIMEKIZUMAB-BKZX reports
0
Deaths
5
Hospitalizations

How Dangerous Is Incorrect dose administered From BIMEKIZUMAB-BKZX?

Of the 209 reports, 5 (2.4%) required hospitalization.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB-BKZX. However, 209 reports have been filed with the FAERS database.

What Other Side Effects Does BIMEKIZUMAB-BKZX Cause?

Product dose omission issue (694) Psoriasis (621) Drug ineffective (402) Product availability issue (364) Off label use (335) Psoriatic arthropathy (301) Injection site pain (263) Therapy interrupted (252) Hidradenitis (233) Inappropriate schedule of product administration (214)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which BIMEKIZUMAB-BKZX Alternatives Have Lower Incorrect dose administered Risk?

BIMEKIZUMAB-BKZX vs BINIMETINIB BIMEKIZUMAB-BKZX vs BIOFLAVONOIDS BIMEKIZUMAB-BKZX vs BIOTIN BIMEKIZUMAB-BKZX vs BIPERIDEN BIMEKIZUMAB-BKZX vs BIRCH TRITERPENES

Related Pages

BIMEKIZUMAB-BKZX Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered BIMEKIZUMAB-BKZX Demographics